StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.02 (-11.19%)

Close on Nov 16, 2026Market cap $466.42KP/E –Yield –

Arcadia Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

Arcadia Biosciences's gross margin for the twelve months ending Jun 30, 2026 was 34.6%. For fiscal 2025 it was 36.2%, against 41.3% the year before. The highest annual figure on record is 93.0% in fiscal 2017.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202536.2%−5.0
FY2024Dec 31, 202441.3%−9.9
FY2023Dec 31, 202351.2%+33.4
FY2022Dec 31, 202217.8%+46.2
FY2021Dec 31, 2021-28.4%−63.7
FY2020Dec 31, 202035.3%−57.7
FY2017Dec 31, 201793.0%+21.0
FY2016Dec 31, 201671.9%−11.6
FY2015Dec 31, 201583.5%+12.1
FY2014Dec 31, 201471.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202643.7%+0.4
Q1 FY2026Mar 31, 202636.4%−6.8
Q4 FY2025Dec 31, 202521.3%−10.7
Q3 FY2025Sep 30, 202532.1%−0.8
Q2 FY2025Jun 30, 202543.4%−8.2
Q1 FY2025Mar 31, 202543.2%−9.1
Q4 FY2024Dec 31, 202432.0%−45.1
Q3 FY2024Sep 30, 202432.9%−4.1
Q2 FY2024Jun 30, 202451.5%+1.6
Q1 FY2024Mar 31, 202452.3%+8.1
Q4 FY2023Dec 31, 202377.1%+98.1
Q3 FY2023Sep 30, 202337.0%+8.8
Q2 FY2023Jun 30, 202349.9%+39.2
Q1 FY2023Mar 31, 202344.2%+51.5
Q4 FY2022Dec 31, 2022-21.0%+51.9
Q3 FY2022Sep 30, 202228.2%+33.8
Q2 FY2022Jun 30, 202210.7%+23.6
Q1 FY2022Mar 31, 2022-7.4%−4.0
Q4 FY2021Dec 31, 2021-72.9%−156.1
Q3 FY2021Sep 30, 2021-5.7%−104.2
Q2 FY2021Jun 30, 2021-13.0%−106.2
Q1 FY2021Mar 31, 2021-3.4%−91.7
Q1 FY2018Mar 31, 201883.2%−6.4
Q4 FY2017Dec 31, 201798.5%+119.5
Q3 FY2017Sep 30, 201793.2%−1.2
Q2 FY2017Jun 30, 201788.3%–
Q1 FY2017Mar 31, 201789.6%–
Q4 FY2016Dec 31, 2016-20.9%–
Q3 FY2016Sep 30, 201694.4%–

More Arcadia Biosciences figures

See a number that looks wrong?